tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market
Advertisement

Ascletis Pharma, Inc. (1672) Similar Stocks

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ascletis Pharma, Inc.
HK$11.38
HK$11.03B
822.81%
0 Buy
1 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$7.38
HK$14.85B
160.78%
CARsgen Therapeutics Holdings Ltd.
HK$24.35
HK$14.02B
447.02%
0 Buy
0 Hold
1 Sell
Moderate Sell
Jiangsu Recbio Technology Co., Ltd. Class H
HK$8.39
HK$4.02B
-6.46%
0 Buy
0 Hold
0 Sell
Hold
Shanghai Henlius Biotech, Inc. Class H
HK$65.30
HK$35.49B
39.89
175.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$16.58
HK$9.52B
107.31
81.20%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1672
Ascletis Pharma, Inc.
10.52
9.38
822.81%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.38
4.55
160.78%
HK:2171
CARsgen Therapeutics Holdings Ltd.
23.85
19.49
447.02%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
8.40
-0.58
-6.46%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
62.00
39.50
175.56%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
16.58
7.51
82.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis